mosapride has been researched along with Gastric Ulcer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobayashi, O; Shimizu, K; Uchida, M | 1 |
| Fujisawa, M; Hori, M; Murata, T; Ozaki, H | 1 |
2 other study(ies) available for mosapride and Gastric Ulcer
| Article | Year |
|---|---|
Gastric emptying after artificial ulceration in rats: differences due to the site of the ulcer and the effects of prokinetic drugs.
Topics: Acetic Acid; Animals; Benzamides; Breath Tests; Dose-Response Relationship, Drug; Gastric Emptying; Gastric Fundus; Kinetics; Male; Metoclopramide; Morpholines; Pylorus; Rats, Sprague-Dawley; Stomach Ulcer | 2017 |
The 5-HT4 receptor agonist mosapride attenuates NSAID-induced gastric mucosal damage.
Topics: Acetylcholine; Administration, Oral; alpha7 Nicotinic Acetylcholine Receptor; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; Dose-Response Relationship, Drug; Gastric Mucosa; Indomethacin; Morpholines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Serotonin 5-HT4 Receptor Agonists; Serotonin Receptor Agonists; Stomach Ulcer | 2010 |